Transforming Growth Factor type β and Smad family signaling in stem cell function

Cytokine and Growth Factor Reviews

Volumn 20, Issue 5-6, 2009, Pages 449-458

  Seuntjens, Eve ^a,b   Umans, Lieve ^a,b   Zwijsen, An ^a,b   Sampaolesi, Maurilio ^c   Verfaillie, Catherine M ^a   Huylebroeck, Danny ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

Author keywords

Activin; Bone Morphogenetic Protein; Nodal; Smad; Smad interacting proteins; Stem cells

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; FOLLISTATIN; MYOD PROTEIN; MYOGENIC FACTOR 5; NOGGIN; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOGENIC PROTEIN 1; PROTEIN NODAL; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA;

ADULT STEM CELL; AMNION CELL; AUTOREGULATION; CELL DIFFERENTIATION; CELL RENEWAL; CEREBROVASCULAR ACCIDENT; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; FEEDBACK SYSTEM; HUMAN; MUSCLE DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PLEIOTROPY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; STEM CELL; SUBVENTRICULAR ZONE; TISSUE REGENERATION; WOUND HEALING;

ADULT; ANIMALS; CELL DIFFERENTIATION; HUMANS; NEUROGENESIS; SIGNAL TRANSDUCTION; SMAD PROTEINS; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 70849107534     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2009.10.005     Document Type: Short Survey

References (162)

1. Feng X.H., and Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21 (2005) 659-693
2. Wu M.Y., and Hill C.S. Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell 16 (2009) 329-343
3. Itoh S., and ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol 19 (2007) 176-184
4. Kitisin K., Saha T., Blake T., Golestaneh N., Deng M., Kim C., et al. Tgf-Beta signaling in development. Sci STKE 2007 399 (2007) cm1
5. Heldin C.H., Landström M., and Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21 (2009) 166-176
6. Xu J., Lamouille S., and Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19 (2009) 156-172
7. Di Guglielmo G.M., Le Roy C., Goodfellow A.F., and Wrana JL. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5 (2003) 410-421 Erratum in: Nat Cell Biol 2003; 5(7):680
8. Le Roy C., and Wrana J.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6 (2005) 112-126
9. Hartung A., Bitton-Worms K., Rechtman M.M., Wenzel V., Boergermann J.H., Hassel S., et al. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol 26 (2006) 7791-7805
10. Chen Y.G. Endocytic regulation of TGF-beta signaling. Cell Res 19 (2009) 58-70
11. Kelley R., Ren R., Pi X., Wu Y., Moreno I., Willis M., et al. A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling. J Cell Biol 184 (2009) 597-609
12. Izzi L., and Attisano L. Ubiquitin-dependent regulation of TGFbeta signaling in cancer. Neoplasia 8 (2006) 677-688
13. Inoue Y., and Imamura T. Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci 99 (2008) 2107-2112
14. Hill C.S. Nucleocytoplasmic shuttling of Smad proteins. Cell Res 19 (2009) 36-46
15. Fuentealba L.C., Eivers E., Ikeda A., Hurtado C., Kuroda H., Pera E.M., et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131 (2007) 980-993
16. Wrighton K.H., and Feng X.H. To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications. Cell Signal 20 (2008) 1579-1591
17. Dreesen O., and Brivanlou A.H. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 3 (2007) 7-17
18. ten Dijke P., and Arthur H.M. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8 (2007) 857-869
19. Wan Y.Y., and Flavell R.A. 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol Rev 220 (2007) 199-213
20. Li M.O., and Flavell R.A. TGF-beta: a master of all T cell trades. Cell 134 (2008) 392-404
21. Luwor R.B., Kaye A.H., and Zhu H.J. Transforming growth factor-beta (TGF-beta) and brain tumours. J Clin Neurosci 15 (2008) 845-855
22. Moutsopoulos N.M., Wen J., and Wahl S.M. TGF-beta and tumors-an ill-fated alliance. Curr Opin Immunol 20 (2008) 234-240
23. Goumans M.J., Liu Z., and ten Dijke P. TGF-beta signaling in vascular biology and dysfunction. Cell Res 19 (2009) 116-127
24. Romano M.F. Targeting TGFbeta-mediated processes in cancer. Curr Opin Drug Discov Dev 12 (2009) 253-263
25. Schmierer B., and Hill C.S. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8 (2007) 970-982
26. Simic P., and Vukicevic S. Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev 16 (2005) 299-308
27. Cain J.E., Hartwig S., Bertram J.F., and Rosenblum N.D. Bone morphogenetic protein signaling in the developing kidney: present and future. Differentiation 76 (2008) 831-842
28. van Wijk B., Moorman A.F., and van den Hoff M.J. Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc Res 74 (2007) 244-255
29. Rochais F., Mesbah K., and Kelly R.G. Signaling pathways controlling second heart field development. Circ Res 104 (2009) 933-942
30. David L., Feige J.J., and Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20 (2009) 203-212
31. Pangas S.A., Li X., Umans L., Zwijsen A., Huylebroeck D., Gutierrez C., et al. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 28 (2008) 248-257
32. Pangas S.A., and Matzuk M.M. Genetic models for transforming growth factor beta superfamily signaling in ovarian follicle development. Mol Cell Endocrinol 225 (2004) 83-91
33. Roy A., and Matzuk M.M. Deconstructing mammalian reproduction: using knockouts to define fertility pathways. Reproduction 131 (2006) 207-219
34. Orvis G.D., Jamin S.P., Kwan K.M., Mishina Y., Kaartinen V.M., Huang S., et al. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse. Biol Reprod 78 (2008) 994-1001
35. Katsuno Y., Hanyu A., Kanda H., Ishikawa Y., Akiyama F., Iwase T., et al. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27 (2008) 6322-6333
36. Piccirillo S.G., Reynolds B.A., Zanetti N., Lamorte G., Binda E., Broggi G., et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444 (2006) 761-765
37. Lee J., Son M.J., Woolard K., Donin N.M., Li A., Cheng C.H., et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13 (2008) 69-80
38. Mukhopadhyay P., Webb C.L., Warner D.R., Greene R.M., and Pisano M.M. BMP signaling dynamics in embryonic orofacial tissue. J Cell Physiol 216 (2008) 771-779
39. Sauka-Spengler T., and Bronner-Fraser M. A gene regulatory network orchestrates neural crest formation. Nat Rev Mol Cell Biol 9 (2008) 557-568
40. Cheng X., Wang Y., He Q., Qiu M., Whittemore S.R., and Cao Q. Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells 25 (2007) 3204-3214
41. Matsuura I., Taniguchi J., Hata K., Saeki N., and Yamashita T. BMP inhibition enhances axonal growth and functional recovery after spinal cord injury. J Neurochem 105 (2008) 1471-1479
42. Colak D., Mori T., Brill M.S., Pfeifer A., Falk S., Deng C., et al. Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells. J Neurosci 28 (2008) 434-446
43. Rhett J.M., Ghatnekar G.S., Palatinus J.A., O'Quinn M., Yost M.J., and Gourdie R.G. Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol 26 (2008) 173-180
44. Moustakas A., and Heldin C.H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98 (2007) 1512-1520
45. Naber H.P., ten Dijke P., and Pardali E. Role of TGF-beta in the tumor stroma. Curr Cancer Drug Targets 8 (2008) 466-472
46. Yang L., and Moses H.L. Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer?. Cancer Res 68 (2008) 9107-9111
47. Padua D., and Massagué J. Roles of TGFbeta in metastasis. Cell Res 19 (2009) 89-102
48. Zhao B.M., and Hoffmann F.M. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA. Mol Biol Cell 17 (2006) 3819-3831
49. Tsukazaki T., Chiang T.A., Davison A.F., Attisano L., and Wrana J.L. SARS, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95 (1998) 779-791
50. Inman G.J., Nicolás F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62 (2002) 65-74
51. Laping N.J., Grygielko E., Mathur A., Butter S., Bomberger J., Tweed C., et al. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62 (2002) 58-64
52. DaCosta Byfield S., Major C., Laping N.J., and Roberts A.B. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 65 (2004) 744-752
53. Yu P.B., Hong C.C., Sachidanandan C., Babitt J.L., Deng D.Y., Hoyng S.A., et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4 (2008) 33-41
54. Niwa H. How is pluripotency determined and maintained?. Development 134 (2007) 635-646
55. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1 (2007) 39-49
56. Gurdon J.B., and Melton D.A. Nuclear reprogramming in cells. Science 322 (2008) 1811-1815
57. Yu J., and Thomson J.A. Pluripotent stem cell lines. Genes Dev 22 (2008) 1987-1997
58. Amabile G., and Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 15 (2009) 59-68
59. Feng B., Ng J.H., Heng J.C., and Ng H.H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4 (2009) 301-312
60. Papapetrou E.P., Tomishima M.J., Chambers S.M., Mica Y., Reed E., Menon J., et al. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci USA (2009) [Epub ahead of print]
61. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38 (2006) 431-440
62. Kalmar T., Lim C., Hayward P., Muñoz-Descalzo S., Nichols J., Garcia-Ojalvo J., et al. Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. PLoS Biol 7 (2009) e1000149
63. MacArthur B.D., Please C.P., and Oreffo R.O.C. Stochasticity and the molecular mechanisms of induced pluripotency. PLoS One 3 8 (2008) e3086
64. Niwa H., Ogawa K., Shimosato D., and Adachi K. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460 (2009) 118-122
65. Ying Q.L., Nichols J., Chambers I., and Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115 (2003) 281-292
66. Humphrey R.K., Beattie G.M., Lopez A.D., Bucay N., King C.C., Firpo M.T., et al. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 22 (2004) 522-530
67. Dahéron L., Opitz S.L., Zaehres H., Lensch M.W., Andrews P.W., Itskovitz-Eldor J., et al. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22 (2004) 770-778 Erratum in: Stem Cells 2007; 25:3273
68. Ogawa K., Saito A., Matsui H., Suzuki H., Ohtsuka S., Shimosato D., et al. Activin-Nodal signaling is involved in propagation of mouse embryonic stem cells. J Cell Sci 120 (2007) 55-65
69. Singla D.K., Schneider D.J., LeWinter M.M., and Sobel B.E. wnt3a but not wnt11 supports self-renewal of embryonic stem cells. Biochem Biophys Res Commun 345 (2006) 789-795
70. Levasseur D.N., Wang J., Dorschner M.O., Stamatoyannopoulos J.A., and Orkin S.H. Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. Genes Dev 22 (2008) 575-580 Erratum in: Genes Dev 2008; 22:954.
71. Sumi T., Fujimoto Y., Nakatsuji N., and Suemori H. STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells. Stem Cells 22 (2004) 861-872
72. Galan-Caridad J.M., Harel S., Arenzana T.L., Hou Z.E., Doetsch F.K., Mirny L.A., et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell 129 (2007) 345-357
73. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133 (2008) 1106-1117
74. Dejosez M., Krumenacker J.S., Zitur L.J., Passeri M., Chu L.F., Songyang Z., et al. Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell 133 (2008) 1162-1174 Erratum in: Cell 2008; 134:692
75. Kim J., Chu J., Shen X., Wang J., and Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132 (2008) 1049-1061 Erratum in: Cell 2008; 133:1290
76. Larsson J., and Karlsson S. The role of Smad signaling in hematopoiesis. Oncogene 24 (2005) 5676-5692
77. Utsugisawa T., Moody J.L., Aspling M., Nilsson E., Carlsson L., and Karlsson S. A road map toward defining the role of Smad signaling in hematopoietic stem cells. Stem Cells 24 (2006) 1128-1136
78. Blank U., Karlsson G., and Karlsson S. Signaling pathways governing stem-cell fate. Blood 111 (2008) 492-503
79. Agius E., Oelgeschläger M., Wessely O., Kemp C., and De Robertis E.M. Endodermal Nodal-related signals and mesoderm induction in Xenopus. Development 127 (2000) 1173-1183
80. De Robertis E.M. Spemann's organizer and self-regulation in amphibian embryos. Nat Rev Mol Cell Biol 7 (2006) 296-302
81. Sasai N., Yakura R., Kamiya D., Nakazawa Y., and Sasai Y. Ectodermal factor restricts mesoderm differentiation by inhibiting p53. Cell 133 (2008) 878-890
82. Piccolo S. p53 regulation orchestrates the TGF-beta response. Cell 133 (2008) 767-769
83. Patthey C., Edlund T., and Gunhaga L. Wnt-regulated temporal control of BMP exposure directs the choice between neural plate border and epidermal fate. Development 136 (2009) 73-83
84. Steventon B., Araya C., Linker C., Kuriyama S., and Mayor R. Differential requirements of BMP and Wnt signalling during gastrulation and neurulation define two steps in neural crest induction. Development 136 (2009) 771-779
85. Linder B., Mentele E., Mansperger K., Straub T., Kremmer E., and Rupp R.A. CHD4/Mi-2beta activity is required for the positioning of the mesoderm/neuroectoderm boundary in Xenopus. Genes Dev 21 (2007) 973-983
86. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147 Erratum in: Science 1998; 282:1827
87. Brons I.G., Smithers L.E., Trotter M.W., Rugg-Gunn P., Sun B., Chuva de Sousa Lopes S.M., et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448 (2007) 191-195
88. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448 (2007) 196-199
89. Chou Y.F., Chen H.H., Eijpe M., Yabuuchi A., Chenoweth J.G., Tesar P., et al. The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell 135 (2008) 449-461
90. Hayashi K., Lopes S.M., Tang F., and Surani M.A. Dynamic equilibrium of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 3 (2008) 391-401
91. Chang H., and Matzuk M.M. Smad5 is required for mouse primordial germ cell development. Mech Dev 104 (2001) 61-67
92. Tremblay K.D., Dunn N.R., and Robertson E.J. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 128 (2001) 3609-3621
93. Hayashi K., Kobayashi T., Umino T., Goitsuka R., Matsui Y., and Kitamura D. SMAD1 signaling is critical for initial commitment of germ cell lineage from mouse epiblast. Mech Dev 118 (2002) 99-109
94. de Sousa Lopes S.M., Roelen B.A., Monteiro R.M., Emmens R., Lin H.Y., Li E., et al. BMP signaling mediated by ALK2 in the visceral endoderm is necessary for the generation of primordial germ cells in the mouse embryo. Genes Dev 18 (2004) 1838-1849
95. Bosman E.A., Lawson K.A., Debruyn J., Beek L., Francis A., Schoonjans L., et al. Smad5 determines murine amnion fate through the control of bone morphogenetic protein expression and signalling levels. Development 133 (2006) 3399-3409
96. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
97. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
98. Suzuki A., Raya A., Kawakami Y., Morita M., Matsui T., Nakashima K., et al. Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification. Nat Clin Pract Cardiovasc Med 3 Suppl. 1 (2006) S114-S122
99. Suzuki A., Raya A., Kawakami Y., Morita M., Matsui T., Nakashima K., et al. Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci USA 103 (2006) 10294-10299
100. Messenger N.J., Kabitschke C., Andrews R., Grimmer D., Núñez Miguel R., Blundell T.L., et al. Functional specificity of the Xenopus T-domain protein Brachyury is conferred by its ability to interact with Smad1. Dev Cell 8 (2005) 599-610
101. James D., Levine A.J., Besser D., and Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132 (2005) 1273-1282
102. Rao B.M., and Zandstra P.W. Culture development for human embryonic stem cell propagation: molecular aspects and challenges. Curr Opin Biotechnol 16 (2005) 568-576
103. Vallier L., Alexander M., and Pedersen R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118 (2005) 4495-4509
104. Xu R.H., Sampsell-Barron T.L., Gu F., Root S., Peck R.M., Pan G., et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3 (2008) 196-206
105. Vallier L., Touboul T., Chng Z., Brimpari M., Hannan N., Millan E., et al. Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One 4 (2009) e6082
106. Fraser S.T., and Baron M.H. Embryonic fates for extraembryonic lineages: new perspectives. J Cell Biochem 107 (2009) 586-591
107. Ravishanker R., Bath A.S., and Roy R. Amnion Bank-the use of long term glycerol preserved amniotic membranes in the management of superficial and superficial partial thickness burns. Burns 29 (2003) 369-374
108. Yu S.J., Soncini M., Kaneko Y., Hess D.C., Parolini O., and Borlongan C.V. Amnion: a potent graft source for cell therapy in stroke. Cell Transplant 18 (2009) 111-118
109. Sakuragawa N., Thangavel R., Mizuguchi M., Hirasawa M., and Kamo I. Expression of markers for both neuronal and glial cells in human amniotic epithelial cells. Neurosci Lett 209 (1996) 9-12
110. Takashima S., Ise H., Zhao P., Akaike T., and Nikaido T. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct 29 (2004) 73-84
111. Tamagawa T., Ishiwata I., and Saito S. Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro. Hum Cell 17 (2004) 125-130
112. Miki T., Lehmann T., Cai H., Stolz D.B., and Strom S.C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 23 (2005) 1549-1559
113. Miki T., Mitamura K., Ross M.A., Stolz D.B., and Strom S.C. Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. J Reprod Immunol 75 (2007) 91-96
114. Parolini O., Alviano F., Bagnara G.P., Bilic G., Bühring H.J., Evangelista M., et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26 (2008) 300-311
115. Marcus A.J., Coyne T.M., Black I.B., and Woodbury D. Fate of amnion-derived stem cells transplanted to the fetal rat brain: migration, survival and differentiation. J Cell Mol Med 12 (2008) 1256-1264
116. Tamagawa T., Ishiwata I., Ishikawa H., and Nakamura Y. Induced in-vitro differentiation of neural-like cells from human amnion-derived fibroblast-like cells. Hum Cell 21 (2008) 38-45
117. Muñoz-Sanjuán I., and Brivanlou A.H. Neural induction, the default model and embryonic stem cells. Nat Rev Neurosci 3 (2002) 271-280
118. Smukler S.R., Runciman S.B., Xu S., and van der Kooy D. Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences. J Cell Biol 172 (2006) 79-90
119. Guillemot F. Spatial and temporal specification of neural fates by transcription factor codes. Development 134 (2007) 3771-3780
120. Gaulden J., and Reiter J.F. Neur-ons and neur-offs: regulators of neural induction in vertebrate embryos and embryonic stem cells. Hum Mol Genet 17 (2008) R60-R66
121. Kitajima H., Yoshimura S., Kokuzawa J., Kato M., Iwama T., Motohashi T., et al. Culture method for the induction of neurospheres from mouse embryonic stem cells by coculture with PA6 stromal cells. J Neurosci Res 80 (2005) 467-474
122. Ying Q.L., Stavridis M., Griffiths D., Li M., and Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 21 (2003) 183-186
123. Piccolo S., Agius E., Leyns L., Bhattacharyya S., Grunz H., Bouwmeester T., et al. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature 397 (1999) 707-710
124. Takenaga M., Fukumoto M., and Hori Y. Regulated Nodal signaling promotes differentiation of the definitive endoderm and mesoderm from ES cells. J Cell Sci 120 (2007) 2078-2090
125. Smith J.R., Vallier L., Lupo G., Alexander M., Harris W.A., and Pedersen R.A. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev Biol 313 (2008) 107-117
126. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., and Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27 (2009) 275-280 Erratum in: Nat Biotechnol 2009; 27:485
127. Hao J., Daleo M.A., Murphy C.K., Yu P.B., Ho J.N., Hu J., et al. Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One 3 (2008) e2904
128. Pucéat M. Protocols for cardiac differentiation of embryonic stem cells. Methods 45 (2008) 168-171
129. Buckingham M. Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev 16 (2006) 525-532
130. Buckingham M., and Montarras D. Skeletal muscle stem cells. Curr Opin Genet Dev 18 (2008) 330-336
131. Cossu G., and Borello U. Wnt signaling and the activation of myogenesis in mammals. EMBO J 18 (1999) 6867-6872
132. Kollias H.D., and McDermott J.C. Transforming growth factor-beta and myostatin signaling in skeletal muscle. J Appl Physiol 104 (2008) 579-587
133. Tagliafico E., Brunelli S., Bergamaschi A., De Angelis L., Scardigli R., Galli D., et al. TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. J Cell Sci 117 (2004) 4377-4388
134. Chargé S.B., and Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84 (2004) 209-238
135. Buckingham M., and Relaix F. The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu Rev Cell Dev Biol 23 (2007) 645-673
136. Tada S., Era T., Furusawa C., Sakurai H., Nishikawa S., Kinoshita M., et al. Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development 132 (2005) 4363-4374
137. Yasunaga M., Tada S., Torikai-Nishikawa S., Nakano Y., Okada M., Jakt L.M., et al. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 23 (2005) 1542-1550
138. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25 (2007) 1015-1024
139. Zhou X., Sasaki H., Lowe L., Hogan B.L., and Kuehn M.R. Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation. Nature 361 (1993) 543-547
140. Rivera-Pérez J.A., and Magnuson T. Primitive streak formation in mice is preceded by localized activation of Brachyury and Wnt3. Dev Biol 288 (2005) 363-371
141. Robertson E.J., Norris D.P., Brennan J., and Bikoff E.K. Control of early anterior-posterior patterning in the mouse embryo by TGF-beta signalling. Philos Trans Roy Soc Lond B: Biol Sci 358 (2003) 1351-1357
142. Jung J., Zheng M., Goldfarb M., and Zaret K.S. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284 (1999) 1998-2003
143. Rossi J.M., Dunn N.R., Hogan B.L., and Zaret K.S. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 15 August (15) (2001) 1998-2009
144. Zaret K.S., and Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 322 (2008) 1490-1494
145. Schmidt C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373 (1995) 699-702
146. Clotman F., Jacquemin P., Plumb-Rudewiez N., Pierreux C.E., Van der Smissen P., Dietz H.C., et al. Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev 19 (2005) 1849-1854
147. Sun X., Meyers E.N., Lewandoski M., and Martin G.R. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev 13 (1999) 1834-1846
148. Saijoh Y., Adachi H., Sakuma R., Yeo C.Y., Yashiro K., Watanabe M., et al. Left-right asymmetric expression of lefty2 and nodal is induced by a signaling pathway that includes the transcription factor FAST2. Mol Cell 5 (2000) 35-47
149. Abrous D.N., Koehl M., and Le Moal M. Adult neurogenesis: from precursors to network and physiology. Physiol Rev 85 (2005) 523-569
150. Gould E. How widespread is adult neurogenesis in mammals?. Nat Rev Neurosci 8 (2007) 481-488
151. Ninkovic J., and Götz M. Signaling in adult neurogenesis: from stem cell niche to neuronal networks. Curr Opin Neurobiol 17 (2007) 338-344
152. Parras C.M., Galli R., Britz O., Soares S., Galichet C., Battiste J., et al. Mash1 specifies neurons and oligodendrocytes in the postnatal brain. EMBO J 23 (2004) 4495-4505
153. Hack M.A., Saghatelyan A., de Chevigny A., Pfeifer A., Ashery-Padan R., Lledo P.M., et al. Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci 8 (2005) 865-872
154. Kohwi M., Osumi N., Rubenstein J.L., and Alvarez-Buylla A. Pax6 is required for making specific subpopulations of granule and periglomerular neurons in the olfactory bulb. J Neurosci 25 (2005) 6997-7003
155. Lim D.A., Tramontin A.D., Trevejo J.M., Herrera D.G., García-Verdugo J.M., and Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 28 (2000) 713-726
156. Gossrau G., Thiele J., Konang R., Schmandt T., and Brüstle O. Bone morphogenetic protein-mediated modulation of lineage diversification during neural differentiation of embryonic stem cells. Stem Cells 25 (2007) 939-949
157. Discher D.E., Mooney D.J., and Zandstra P.W. Growth factors, matrices, and forces combine and control stem cells. Science 324 (2009) 1673-1677
158. Bibikova M., Laurent L.C., Ren B., Loring J.F., and Fan J.B. Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell 2 (2008) 123-134
159. Derynck R., and Akhurst R.J. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 9 (2007) 1000-1004
160. Watabe T., and Miyazono K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res 19 (2009) 103-115
161. Guzman-Ayala M., Lee K.L., Mavrakis K.J., Goggolidou P., Norris D.P., and Episkopou1 V. Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells. PLoS One 4 (2009) e4268
162. Clarke D.C., and Liu X. Decoding the quantitative nature of TGF-beta/Smad signaling. Trends Cell Biol 18 (2008) 430-442